Febutop Tablet (Febuxostat) | Used for Gout Treatment and Uric Acid Reduction
Febutop Tablet (Febuxostat) is a xanthine oxidase inhibitor used to treat chronic gout and high uric acid levels (hyperuricaemia). Reduces uric acid production, preventing painful gout attacks and uric acid crystal deposits in joints.
Product Overview
Febutop Tablet is a potent, non-purine selective xanthine oxidase inhibitor containing Febuxostat. Febutop Tablet is a primary therapeutic agent used for the chronic management of hyperuricemia (excessive uric acid in the blood) in patients with gout. By targeting the underlying cause of uric acid overproduction, it helps prevent the formation of urate crystals, thereby reducing the frequency of painful gout flares and protecting the joints from long-term damage.
Product Composition
- Active Ingredient: Febuxostat
- Pharmacological Class: Xanthine Oxidase Inhibitor (XOI)
- Common Strengths: 40 mg, 80 mg
- Formulation: Film-coated tablets
- Excipients: May include lactose monohydrate, microcrystalline cellulose, and croscarmellose sodium
Product Specifications
| Feature | Specification |
| Drug Category | Antigout / Antihyperuricemic |
| Therapeutic Class | Xanthine Oxidase Inhibitor |
| Target Enzyme | Xanthine Oxidase (Oxidized & Reduced forms) |
| Metabolism | Extensive Hepatic (Liver) |
| Excretion | Renal and Fecal |
| Storage | Store at room temperature (20°C to 25°C) |
Mechanism of Action
- Enzyme Inhibition: Febuxostat works by selectively inhibiting xanthine oxidase, the enzyme responsible for converting hypoxanthine to xanthine, and subsequently xanthine to uric acid.
- Dual-Action Blockade: Unlike older inhibitors, Febuxostat effectively blocks both the oxidized and reduced forms of the enzyme. This results in a more potent and sustained reduction of serum uric acid levels.
- Uric Acid Reduction: By decreasing the production of uric acid, the concentration of urate in the blood falls below the saturation point.
- Crystal Dissolution: Over time, maintaining low serum uric acid levels allows existing monosodium urate crystals (tophi) in the joints and tissues to slowly dissolve, preventing further inflammatory responses.
Key Benefits
- Superior Urate Lowering: Provides a more robust reduction in serum uric acid compared to standard doses of traditional agents like allopurinol.
- Joint Protection: Regular use significantly reduces the incidence of gouty arthritis flares and prevents the progression of joint destruction.
- Convenient Once-Daily Dosing: The long half-life of the medication allows for a simple daily routine, improving patient adherence to chronic therapy.
- Minimal Renal Dosing Adjustments: Because it is metabolized primarily by the liver, it is often a preferred option for patients with mild-to-moderate kidney impairment.
- Selective Profile: It does not inhibit other enzymes involved in purine or pyrimidine metabolism, which contributes to its specific therapeutic focus and safety profile.
Precautions
Medical supervision
- Use Febutop Tablet (Febuxostat) only under proper medical supervision
- Do not stop or change dose without advice
- Regular monitoring of uric acid levels is important
- Treatment is usually long term for gout control
Health conditions
| Condition | Precaution |
|---|---|
| Heart disease | May increase risk of cardiovascular events in some patients |
| Liver disease | Requires dose adjustment and monitoring |
| Kidney disease | Use with caution; monitoring needed |
| Thyroid disorders | May require careful monitoring |
| History of gout flares | Flares may increase at treatment start |
Gout flare risk
- Gout attacks may temporarily increase at the start of therapy
- Do not stop medicine during a flare unless advised
- Preventive medicines may be prescribed initially
Liver safety
- Liver function tests may be required before and during treatment
- Report yellowing of skin, dark urine, or fatigue
Heart safety
- May carry risk in patients with existing heart disease
- Report chest pain, breathlessness, or irregular heartbeat
- Use lowest effective dose as advised
Kidney and hydration
- Maintain good hydration to help uric acid removal
- Kidney function may need regular monitoring
Lifestyle precautions
- Limit alcohol intake (especially beer and spirits)
- Avoid high-purine foods (red meat, organ meat, seafood)
- Maintain healthy weight and exercise regularly
Monitoring advice
- Regular uric acid blood tests are needed
- Report severe joint pain, swelling, or persistent symptoms
- Follow up visits are important for long term management
Usage
Febutop Tablet is a long-term antihyperuricemic therapy. Unlike medications used for acute pain, this treatment is designed to regulate the body's internal chemistry over time. Consistency in administration is the most important factor in preventing the accumulation of urate crystals.
Dosage and Administration
Adhering to these clinical protocols helps maintain stable uric acid levels and ensures the medication is tolerated effectively.
Administration Timing: The tablet should be taken once daily, ideally at the same time each day to maintain consistent enzyme inhibition.
Oral Routine: The tablet can be taken with or without food. It should be swallowed whole with a full glass of water.
Flare Management: During the first few months of starting Febuxostat, an increase in gout flares may occur as urate crystals begin to dissolve. It is common to take a low-dose NSAID or colchicine alongside Febutop during this initiation phase to manage these temporary symptoms.
- Continuous Therapy: Do not stop taking the medication during a gout flare. Febutop is a preventative treatment and must be continued even when symptoms are not present to keep uric acid levels low.
Hydration: It is recommended to drink plenty of fluids (at least 2 liters of water per day) to assist the kidneys in excreting uric acid and to prevent the formation of kidney stones.
Monitoring: Regular blood tests to monitor serum uric acid levels and liver function (LFTs) are standard practice during therapy to ensure the dosage is correct and safe.
Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed one. Do not take a double dose.
Uses
Febutop Tablet is indicated for the chronic management of conditions associated with the overproduction of uric acid.
Primary Therapeutic Uses
Chronic Management of Hyperuricemia: Used to lower high levels of uric acid in patients with a history of gouty arthritis.
Prevention of Gout Flares: Reduces the frequency and intensity of painful attacks characterized by swelling, redness, and heat in the joints (typically the big toe, ankle, or knee).
Treatment of Tophaceous Gout: Helps in the gradual dissolution of tophi—visible deposits of urate crystals that can form under the skin or around joints.
Joint Preservation: Prevents the long-term joint erosion and bone damage caused by persistent monosodium urate deposits.
Hyperuricemia in Kidney Impairment: Utilized as a specialized alternative for patients with chronic kidney disease (CKD) who cannot tolerate or achieve targets with other xanthine oxidase inhibitors.
Tumor Lysis Syndrome (TLS) Prevention: Occasionally used in a clinical setting to prevent high uric acid levels in patients undergoing chemotherapy for certain types of cancer.
FAQs
Q: What is Febutop Tablet used for?
A: Febutop Tablet is used to treat chronic gout and high uric acid levels (hyperuricaemia) in adults. It helps prevent painful gout attacks and reduces the deposit of uric acid crystals in the joints and kidneys.
Q: How does Febutop Tablet work?
A: Febuxostat works by blocking the xanthine oxidase enzyme, which is responsible for producing uric acid in the body. By reducing uric acid production, it lowers uric acid levels in the blood and prevents gout attacks and crystal deposits in joints and kidneys.
Q: How should Febutop Tablet be taken?
A: Take it once daily with or without food. Swallow the tablet whole with a glass of water. Take it at the same time each day for best results. Always follow your doctor's instructions regarding the dose and duration of treatment.
Q: What are the common side effects of Febutop Tablet?
A: Common side effects include nausea, joint pain, gout flares, headache, diarrhoea, rash, dizziness, and liver enzyme changes. Most are mild and resolve on their own. Consult your doctor if they persist or worsen.
Q: Can Febutop Tablet cause gout attacks when first started?
A: Yes, gout flares may occur during the initial weeks of treatment as uric acid crystals begin to dissolve and shift in the joints. Your doctor may prescribe anti-inflammatory medicines such as colchicine or NSAIDs to prevent these flares during the early stages of treatment.
Q: Who should not take Febutop Tablet?
A: Avoid if you are allergic to Febuxostat. Also avoid if you are taking azathioprine or mercaptopurine as Febuxostat may increase their toxicity to dangerous levels.
Q: Can Febutop Tablet be used during pregnancy?
A: Febutop Tablet is not recommended during pregnancy as its safety has not been established. Consult your doctor before taking this medicine if you are pregnant or planning to become pregnant.
Q: Is Febutop Tablet safe during breastfeeding?
A: Febutop Tablet is not recommended during breastfeeding. Consult your doctor before taking this medicine while breastfeeding.
Q: Can Febutop Tablet be used in children?
A: Febutop Tablet is not recommended for use in children and adolescents below 18 years of age as its safety and efficacy have not been established in this age group.
Q: Can Febutop Tablet affect the liver?
A: Yes, Febutop Tablet may rarely cause liver function abnormalities. Your doctor may monitor liver function tests periodically during treatment. Seek medical attention immediately if you experience symptoms such as yellowing of the skin or eyes, dark urine, or severe stomach pain.
Q: Can Febutop Tablet be used in patients with kidney disease?
A: Febutop Tablet can be used in patients with mild to moderate kidney disease without dose adjustment. However, it should be used with caution in severe kidney impairment.
Q: Can Febutop Tablet be used in patients with heart disease?
A: Febutop Tablet should be used with caution in patients with heart disease, as studies have suggested a possible increased risk of heart-related events. Inform your doctor if you have a history of heart attack or stroke before starting this medicine.
Q: Can I drink alcohol while taking Febutop Tablet?
A: It is advisable to limit or avoid alcohol while taking Febutop Tablet as alcohol increases uric acid production and may trigger gout attacks, reducing the effectiveness of the medicine.
Q: How long does it take for Febutop Tablet to work?
A: Febutop Tablet may take several weeks to months to significantly lower uric acid levels and reduce the frequency of gout attacks. Continue taking it as prescribed even if you do not notice immediate improvement.
Q: Does Febutop Tablet require regular monitoring?
A: Yes, your doctor may monitor uric acid levels and liver function tests periodically during treatment to ensure the medicine is working effectively and to detect any side effects early.
Interactions
Azathioprine and Mercaptopurine
- Can cause dangerous increase in their levels
- Risk of severe toxicity is high
- Combination should generally be avoided
Theophylline
- May increase theophylline levels in blood
- Risk of side effects like nausea, tremors, or palpitations
- Dose adjustment and monitoring may be required
Anti cancer medicines
- May interact with medicines affecting cell metabolism
- Requires specialist supervision if used together
NSAIDs (pain relievers)
- No major direct interaction, but kidney function should be monitored
- Combined use may increase kidney stress in sensitive patients
Diuretics (water tablets)
- May affect uric acid levels and kidney function
- Monitoring is important in long term use
Warfarin and blood thinners
- May slightly affect anticoagulant response in some cases
- INR monitoring may be advised
General advice
- Inform about all ongoing medicines before use
- Avoid starting or stopping medicines without medical guidance
- Regular monitoring of uric acid and liver function may be required
| Manufacturer | : | Healing Pharma |
| Trade Name | : | Uloric |
| Generic Search | : | Febuxostat |
| Strength | : | 40mg, 80mg |
Latest Products
